Author: Khyati Shah

The Director Controller General of India (DCGI) has found the nation’s first mRNA-based Covid-19 vaccine, developed by Gennova Biopharmaceuticals, to be safe and approved it for phase 2/3 trials. The Pune-based... Read More

The Director Controller General of India (DCGI) has found the nation’s first mRNA-based Covid-19 vaccine, developed by Gennova Biopharmaceuticals, to be safe and approved it for phase 2/3 trials. The Pune-based... Read More

The Indian Women’s Health Report 2021 surveying 1,000 working women aged between 25 and 55 across seven cities has revealed that around half of them are not comfortable talking about... Read More

Kolkata, Sep 08 (UNI) The Indian Women’s Health Report 2021 surveying 1000 working women aged between 25 to 55 years across seven cities has revealed that around half of the... Read More

The Indian Women’s Health Report 2021 surveying 1000 working women aged between 25 to 55 years across seven cities has revealed that around half of the women surveyed are... Read More

At a time when female workforce participation is dropping to a new low at the national level, the discrimination being faced by women over their health is high. A report,... Read More

The mRNA-based vaccine has been developed in partnership with Department of Biotechnology (DBT) and Biotechnology Industry Research Assistance Council (BIRAC). •Gennova Biopharmaceuticals Ltd., which is a Pune-based biotechnology company, had submitted... Read More

The mRNA-based vaccine has been developed in partnership with Department of Biotechnology (DBT) and Biotechnology Industry Research Assistance Council (BIRAC). •Gennova Biopharmaceuticals Ltd., which is a Pune-based biotechnology company, had submitted... Read More

The Central Drugs Standard Control Organisation (CDSCO), India's National Regulatory Authority, has approved Gennova Biopharmaceuticals Limited's work on the country's first mRNA-based COVID-19 vaccine for its clinical data of the... Read More

The Central Drugs Standard Control Organisation (CDSCO), India's National Regulatory Authority, has approved Gennova Biopharmaceuticals Limited's work on the country's first mRNA-based COVID-19 vaccine for its clinical data of the... Read More